Funding
EPFL Innogrant · Biotech

GenoRobotics receives CHF100,000 EPFL Innogrant

The field-DNA project, now continued as DecodeNAture, will complete and test its portable analysis technology.

By RoundOS Funding desk

GenoRobotics received a CHF100,000 EPFL Innogrant, announced on December 15, 2025. The award supports prototype completion and field pilots. The commercial venture emerging from the project now operates as DecodeNAture.

Its team develops portable DNA tools for species identification. The approach brings molecular workflows closer to agriculture, biodiversity and biosecurity decisions, reducing reliance on samples being transported to central laboratories.

Use of funds

Complete and field-validate the portable DNA analysis prototype.

Funding history

EPFL Innogrant · This roundCHF 100K

Sources

  1. EPFL startup grant award announcementactu.epfl.ch · Dec 15, 2025
  2. decode-nature.com
  3. genorobotics.org

Similar rounds

All Biotech rounds →
ALLOX

ALLOX combines high-throughput genetics, experimental biology and AI to find functional sites on proteins and develop targeted small-molecule medicines.

$10.5MSeed · Oct 29, 2026
Dren Bio

Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.

$350MPrivate financing · Oct 29, 2026
BioGeometry

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

UndisclosedSeries A+ · Oct 28, 2026
IntegriCulture

IntegriCulture develops cell-culture systems and production technology for cellular foods, cosmetics and other biological materials.

UndisclosedFunding round · Oct 28, 2026

Related